Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Indoleamine 2,3-dioxygenase 1 in circumventing checkpoint inhibitor responses: Updated
Arian Charehjoo, Jamal Majidpoor, Keywan Mortezaee
International Immunopharmacology (2023) Vol. 118, pp. 110032-110032
Closed Access | Times Cited: 16

Showing 16 citing articles:

B7-H3 immunoregulatory roles in cancer
Keywan Mortezaee
Biomedicine & Pharmacotherapy (2023) Vol. 163, pp. 114890-114890
Open Access | Times Cited: 26
Immune checkpoint inhibitors in colorectal cancer: limitation and challenges
Suying Yan, Wanting Wang, Zhiqiang Feng, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 13
Deciphering the tumor immune microenvironment of imatinib-resistance in advanced gastrointestinal stromal tumors at single-cell resolution
Xuechao Liu, Jing Yu, Yi Li, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 8
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
Simone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102843-102843
Open Access | Times Cited: 7
Combination of epidrugs with immune checkpoint inhibitors in cancer immunotherapy: From theory to therapy
Ruoyu Guo, Jixia Li, Jinxia Hu, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110417-110417
Open Access | Times Cited: 16
Physiological and pathophysiological effects of L-tryptophan’s metabolites on the brain and immunity – a challenge for drug development
Petar Iliev, Samuil Ivanov, S Lazarov, et al.
Pharmacia (2025) Vol. 72, pp. 1-7
Open Access
B7x in cancer immunity and immunotherapy
Keywan Mortezaee
International Immunopharmacology (2023) Vol. 118, pp. 110133-110133
Closed Access | Times Cited: 10
B7-H3 is associated with the armored-cold phenotype and predicts poor immune checkpoint blockade response in melanoma
Bozhi Shen, Jie Mei, Rui Xu, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155267-155267
Closed Access | Times Cited: 3
High indoleamine 2,3-dioxygenase transcript levels predict better outcome after front-line cancer immunotherapy
Yu Fujiwara, Shumei Kato, Daisuke Nishizaki, et al.
iScience (2024) Vol. 27, Iss. 4, pp. 109632-109632
Open Access | Times Cited: 3
Selective targeting or reprogramming of intra-tumoral Tregs
Keywan Mortezaee
Medical Oncology (2024) Vol. 41, Iss. 3
Closed Access | Times Cited: 2
Reinstating immunogenicity using bispecific anti-checkpoint/agent inhibitors
Keywan Mortezaee, Jamal Majidpoor
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114621-114621
Open Access | Times Cited: 4
Lymphocyte activation gene-3 as a candidate target for combo anti-programmed death-(ligand) 1 therapy of cancer
Keywan Mortezaee
Process Biochemistry (2024) Vol. 137, pp. 143-152
Closed Access | Times Cited: 1
Improved automated one-pot two-step radiosynthesis of (S)-[18F]FETrp, a radiotracer for PET imaging of indoleamine 2,3-dioxygenase 1 (IDO1)
Aurélie Maisonial‐Besset, David Kryza, Klaus Kopka, et al.
EJNMMI Radiopharmacy and Chemistry (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Expression of IDO1 in Tumor Microenvironment Significantly Predicts the Risk of Recurrence/Distant Metastasis for Patients With Esophageal Squamous Cell Carcinoma
Cen Qiu, Qingyuan Lin, Saiyan Ji, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 12, pp. 100263-100263
Closed Access | Times Cited: 3
Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma
Yaojun Peng, Lingxiong Wang, Juan Yang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Effects of Tolerant Nanoparticles Loaded with Various Regulatory Molecules on the Development of Experimental Autoimmune Encephalomyelitis
Weiwei Liang, Lin Cong, Hongmei Yu
Science of Advanced Materials (2023) Vol. 15, Iss. 7, pp. 926-935
Closed Access
Page 1

Scroll to top